SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689813-20-000030
Filing Date
2020-04-30
Accepted
2020-04-30 17:25:06
Documents
14
Period of Report
2020-04-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20200430.htm   iXBRL 8-K 62552
  Complete submission text file 0001689813-20-000030.txt   205233

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20200430.xsd EX-101.SCH 2583
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20200430_cal.xml EX-101.CAL 726
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20200430_def.xml EX-101.DEF 1663
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20200430_lab.xml EX-101.LAB 23938
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20200430_pre.xml EX-101.PRE 12650
7 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20200430_htm.xml XML 10563
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 20836925
SIC: 2834 Pharmaceutical Preparations